Hiv therapy news

Here are some recent news updates on HIV therapy:

New HIV Treatments and Regimens

  1. Cabotegravir: The FDA has approved cabotegravir, a long-acting injectable HIV treatment, for use in combination with other antiretroviral therapies (ARTs). This treatment offers a new option for people living with HIV who have difficulty adhering to daily oral medications. (Source: FDA)
  2. Bictegravir: The FDA has approved bictegravir, a new HIV integrase inhibitor, for use in combination with other ARTs. This treatment has been shown to be effective in reducing viral load and improving treatment outcomes. (Source: FDA)
  3. Dolutegravir-based regimen: A study published in The Lancet found that a dolutegravir-based regimen was effective in reducing viral load and improving treatment outcomes in people living with HIV who had previously failed other treatments. (Source: The Lancet)

Advances in HIV Cure Research

  1. HIV remission: A study published in the journal Nature Medicine found that a small group of people living with HIV were able to achieve long-term remission from the virus after receiving a combination of antiretroviral therapy and a stem cell transplant. (Source: Nature Medicine)
  2. HIV cure breakthrough: Researchers at the University of California, San Francisco, have made a breakthrough in HIV cure research, discovering a new way to eliminate HIV-infected cells from the body. (Source: University of California, San Francisco)

New Diagnostics and Monitoring Tools

  1. Point-of-care HIV testing: A new point-of-care HIV testing device has been developed, allowing for rapid and accurate testing for HIV in resource-limited settings. (Source: World Health Organization)
  2. Digital monitoring: A study published in the Journal of Acquired Immune Deficiency Syndromes found that digital monitoring of HIV treatment adherence and viral load was effective in improving treatment outcomes and reducing the risk of treatment failure. (Source: Journal of Acquired Immune Deficiency Syndromes)

Global HIV Treatment Access

  1. Global HIV treatment coverage: According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), global HIV treatment coverage has increased to 73% of people living with HIV, with 21.7 million people receiving antiretroviral therapy. (Source: UNAIDS)
  2. HIV treatment access in low- and middle-income countries: A study published in The Lancet found that HIV treatment access has improved significantly in low- and middle-income countries, with 64% of people living with HIV in these countries receiving antiretroviral therapy. (Source: The Lancet)

These are just a few examples of recent news updates on HIV therapy. If you're interested in staying up-to-date on the latest developments, I recommend following reputable sources such as the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the International AIDS Society (IAS).